Multi-omics analysis identifies LANCL2 as a potential biomarker for the diagnosis and prognosis of gastric cancer - Fang, Xidong; Liu, Mengxiao; Ren, Qian; Li, Renpeng; Wu, Guozhi; Yuan, Hao; Zheng, Ya; Gou, Xi; Wang, Yuping; Zhou, Yongning (Scientific reports, 2025)
Keywords: 631/114; 631/67; Biomarkers; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cancer; Cell cycle; Cell Line, Tumor; Cell proliferation; Disease management; DNA repair; Enzymes; Female; Ferroptosis; Gastric cancer; Gene Expression Regulation, Neoplastic; Gene set enrichment analysis; Guanylate cyclase; Humanities and Social Sciences; Humans; Immune checkpoint; LANCL2; Male; Malignancy; Medical prognosis; Membrane Proteins - genetics; Membrane Proteins - metabolism; Metastases; Middle Aged; Morbidity; mRNA; multidisciplinary; Multiomics; Pathogenesis; Prognosis; Public health; Science; Science (multidisciplinary); Stomach adenocarcinoma; Stomach Neoplasms - diagnosis; Stomach Neoplasms - genetics; Stomach Neoplasms - metabolism; Stomach Neoplasms - mortality; Stomach Neoplasms - pathology; Therapeutic targets; Tumorigenesis; Tumors; LANCL2; Tumorigenesis; Prognosis; Stomach adenocarcinoma